- Home
- VTR
VTR
Ventas Inc.
as 11-20-2024 4:00pm EST
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 27.3B | IPO Year: | 1998 |
| Target Price: | $60.40 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $41.45 - $67.61 | Next Earning Date: | 10-30-2024 |
| Revenue: | $4,797,115,000 | Revenue Growth: | 10.05% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 6.71% |
Stock Insider Trading Activity of Ventas Inc. (VTR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CAFARO DEBRA A | VTR | Chairman and CEO | Oct 29 '24 | Sell | $66.42 | 155,333 | $10,295,042.58 | 986,717 | |
| CAFARO DEBRA A | VTR | Chairman and CEO | Oct 24 '24 | Sell | $66.10 | 80,767 | $5,338,532.98 | 986,717 | |
| Bulgarelli Peter J. | VTR | EVP OM&R-Ventas/Pres&CEO-LHS | Sep 10 '24 | Sell | $65.13 | 7,500 | $487,847.70 | 89,295 | |
| CAFARO DEBRA A | VTR | Chairman and CEO | Sep 9 '24 | Sell | $63.81 | 22,690 | $1,447,873.86 | 986,717 | |
| Bulgarelli Peter J. | VTR | EVP OM&R-Ventas/Pres&CEO-LHS | Aug 26 '24 | Sell | $60.08 | 7,500 | $451,114.31 | 89,295 | |
| CAFARO DEBRA A | VTR | Chairman and CEO | Aug 26 '24 | Sell | $60.08 | 41,288 | $2,482,568.06 | 986,717 |
Latest Ventas Inc. News
VTR Breaking Stock News: Dive into VTR Ticker-Specific Updates for Smart Investing
Business Wire
16 hours ago
Ventas Earns Nareit 2024 Healthcare "Leader in the Light" Award
MT Newswires
2 days ago
Evercore ISI Adjusts Ventas' Price Target to $72 From $70, Keeps Outperform Rating
MT Newswires
3 days ago
Wells Fargo Raises Ventas Price Target to $72 From $71, Maintains Overweight Rating
MT Newswires
3 days ago
Evercore ISI Adjusts Price Target on Ventas to $70 From $72, Maintains Outperform Rating
Business Wire
6 days ago
Ventas to Participate in Investor Meetings at Nareit’s REITworld 2024 Annual Conference
MT Newswires
6 days ago
Baird Raises Ventas Price Target to $65 From $60
MT Newswires
7 days ago
Ventas Prices $677 Million Offering Related to Wells Fargo Forward Sale Deal
Business Wire
7 days ago
Ventas Announces Pricing of an Underwritten Offering of 10.6 Million Shares of Common Stock
Compare VTR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VTR Ventas Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.